REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: -5.00 (-1.02%)
Spread: 10.00 (2.083%)
Open: 490.00
High: 490.00
Low: 485.00
Prev. Close: 490.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Oct 2022 07:00

RNS Number : 9391D
System1 Group PLC
25 October 2022
 

 

 

25 October 2022

 

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

 

Half Year Trading Update

 

 

In advance of its interim results announcement due at the end of November, System1 today issues an update on trading for the half year ended 30 September 2022 (H1).

 

Data revenue grew 38% to £6.2m (H1 last year: £4.5m) representing 59% of H1 revenue, the highest absolute six-month revenue for our automated predictions and the highest proportion of Group revenue since launching in 2020. The continued Data growth was offset by a 46% decline in consultancy from £7.9m to £4.3m. Consequently, total H1 revenue declined 15% on the comparable period last year to £10.5m from £12.4m in H1 last year, in line with management's expectations.

 

Gross profit fell by 18% to £8.5m (H1 last year: £10.4m) on revenue down 15% versus the comparable period last year, with the reduction in margin due mainly to region and product mix. Adjusted Operating Costs reduced by 1% to £9.0m, and the Company expects to report an Adjusted Pre-Tax Loss of £0.4m in the first half, compared to an Adjusted Pre-Tax Profit of £1.3m in H1 last year. At Statutory Pre-Tax Profit level, the Company expects to break even in the first half, down £1.3m on H1 last year.

 

H1 period-end cash, net of borrowings, was £6.6m, compared to £8.7m at end-March 2022, an outflow for the period reflecting the Adjusted Pre-Tax higher working capital and the repurchase of shares on market.

 

The Board is encouraged by the strong growth in "Test Your" Data products which now represent almost 60% of Group revenues in H1 and grew 17% compared to the preceding half year. It is clear that the transition from bespoke research consultancy to platform-based "Test Your" data is well underway, and the Board expects the drag from declining bespoke research consultancy to reduce progressively.

 

US Litigation

On 9 November 2021, System1 announced that it had filed a complaint for trademark infringement, unfair competition and deceptive trade practices at the United States District Court Southern District of New York against System1 LLC ("LLC") over their infringing use of the mark "System1".

Earlier this month, the U.S. District Court Southern District of New York rejected LLC's motion to dismiss the complaint which means the case will proceed as planned.

In the same week, we received positive news for the next stage in the legal case by successfully registering the mark "System1" with the United States Patent and Trademark Office for use in classes 35 and 38, matching the registrations already held in the UK, EU, and other territories.

 

Strategic Review

As announced on 31 August 2022, the Board is conducting a review of its strategic options for growing the business and increasing shareholder value. The Board also decided to postpone the previously planned tender offer and share buyback programme, with decisions on future returns of capital being considered as part of the overall strategic review. As previously announced, the Board intends to update the market on its strategic review alongside the interim results announcement on 30 November.

 

 

Further information on the Company can be found at www.system1group.com.

 

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

 

John Kearon, Founder and Chief Executive Officer

 

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSSNRUBURUAA
Date   Source Headline
23rd Apr 202111:16 amRNSCorrection re Directors Dealings
23rd Apr 20219:40 amRNSExercise of Options, Directors Dealings and TVR
21st Apr 20217:00 amRNSTrading Update
30th Mar 20217:00 amRNSChange in Executive Job Titles
15th Feb 202112:42 pmRNSBoard Changes
12th Feb 202111:00 amRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20204:30 pmRNSGrant of Options
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20206:27 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSInterim Results
14th Oct 20207:00 amRNSTrading Update
12th Oct 20201:40 pmRNSHolding(s) in Company
7th Oct 20202:33 pmRNSHolding(s) in Company
24th Sep 20204:08 pmRNSHolding(s) in Company
4th Aug 20209:39 amRNSDirector/PDMR Shareholding - Replacement
3rd Aug 20205:33 pmRNSDirector/PDMR Shareholding
31st Jul 20206:34 pmRNSResult of AGM
6th Jul 20204:33 pmRNSAnnual Report and Notice of AGM
3rd Jul 202012:22 pmRNSDirector/PDMR Shareholding
2nd Jul 202010:04 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSFinancial results to 31 March 2020
26th Jun 20202:00 pmRNSExercise of Options and Total Voting Rights
26th Jun 20207:00 amRNSDirectorate Change
26th Jun 20207:00 amRNSDirectorate Change
27th Apr 20207:00 amRNSTrading Update
3rd Apr 20207:00 amRNSChief Financial Officer Resignation
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSTrading Update and Planned Share Buyback
23rd Dec 20193:30 pmRNSExercise of Options and Total Voting Rights
7th Nov 20199:29 amRNSDividend Declaration
7th Nov 20197:00 amRNSInterim Results
14th Oct 20197:00 amRNSTrading Update
5th Sep 20197:00 amRNSGrant of Options
1st Aug 20197:00 amRNSResult of AGM
28th Jun 201912:30 pmRNSAnnual Report and Notice of AGM
12th Jun 20197:00 amRNSHolding(s) in Company
6th Jun 20197:00 amRNSDividend Declaration
6th Jun 20197:00 amRNSFinancial results to 31 March 2019
18th Apr 20197:00 amRNSGrant of Options
15th Apr 20197:00 amRNSTrading Update
19th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20188:24 amRNSHolding(s) in Company
6th Nov 20187:00 amRNSPDMR Shareholding
2nd Nov 20184:08 pmRNSDividend Declaration
2nd Nov 20187:00 amRNSInterim Results
15th Oct 20187:00 amRNSTrading Update
2nd Oct 20189:09 amRNSHolding(s) in Company
28th Sep 201810:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.